FTC said the "Big 3 PBMs" — CVS’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx — imposed markups of hundreds to thousands of percent on critical drugs, including those ...

The companies say the suit is baseless and defend their practices. CVS, UnitedHealth and Cigna in October asked the FTC to disqualify Chair Linda Khan from the insulin suit, citing alleged bias ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Cigna’s Express Scripts called the report ... what our health plans spend on medications in a year” and said the FTC had failed to address the underlying causes of rising drug prices.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

All three also previously countersued the FTC, and Cigna noted that the reports are based on small subsets of data. Meanwhile, its Express Scripts PBM data shows that specialty generic medications ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

Cigna’s Express Scripts called the report “another set of misleading conclusions based on a subset of medications that represent less than 2% of what our health plans spend on medications in a year” ...